PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO‐II anovulation and association with metabolic factors
The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Objective The current report aims to compare the prevalence of polycystic ovary syndrome (PCOS) diagnosed according to the new Rotterdam criteria (Rott‐PCOS) versus the previous criteria as formulated by the National Institutes of Health (NIH) (NIH‐PCOS) in women with normogonadotropic (WHO‐II) anovulation and assess the frequency of obesity and related factors determined in these women. Design Cohort study based on large anovulation screening database. Setting Two large tertiary referral centres for reproductive medicine. Population WHO‐II normogonadotropic, anovulatory, infertility cases. Methods WHO‐II cases were extracted from the screening database and classified according to both the Rotterdam and NIH criteria for PCOS. Within these two classes, the prevalence of obesity, hyperglycaemia and insulin resistance was assessed and compared and their relation to the difference in diagnostic criteria applied was analysed. Main outcome measures Prevalence of diagnosis PCOS in the WHO‐II anovulation group. Prevalence of obesity, hyperglycaemia and insulin resistance in the two diagnostic classes. Results The Rott‐PCOS group appeared to be more than 1.5 times larger than the group classified as NIH‐PCOS (91 versus 55% of the WHO‐II cohort). Especially, women with ovarian dysfunction and polycystic ovaries at ultrasound scan, but without hyperandrogenism, were added to the PCOS diagnostic group. The Rott‐PCOS exhibited a lower frequency of obesity, hyperglycaemia and insulin resistance compared with the NIH‐PCOS group. Obese women in the Rott‐PCOS group without androgen excess had a different metabolic profile compared with obese women in the NIH‐PCOS group, with lower rates of hyperglycaemia and hyperinsulinism, despite comparable distributions of body weight. Conclusion The present findings indicate that with the new Rotterdam consensus criteria, oligo/anovulatory women with less severe metabolic derangement will be added to the heterogeneous group of women with PCOS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
Dunaif, A. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,458
Men at risk: occupation and male infertility
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,387
Amenorrhea associated with bilateral polycystic ovaries
Stein, I. F., & Leventhal, M. L. (1935) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30642-6 · Cited by 2,121
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis
Dunaif, A. (1997) · Endocrine Reviews · doi:10.1210/er.18.6.774 · Cited by 1,155
Andrology: Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients
Balen, A. H., Conway, G. S., Kaltsas, G., Techatraisak, K., Manning, P. J., West, C., & Jacobs, H. S. (1995) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a136243 · Cited by 1,060
Cited by
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132
“, NIH 1990) can lead to a significant increase in the population considered to be affected (16).”
BackgroundDiamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
March, W. A., Moore, V. M., Willson, K. J., Phillips, D. I. W., Norman, R. J., & Davies, M. J. (2010) · Human Reproduction · doi:10.1093/humrep/dep399 · Cited by 1,799
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., & Azziz, R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.217 · Cited by 1,488
“and even more individuals according to the broader Rotterdam criteria”
BackgroundState-of-the-science of endocrine disrupting chemicals, 2012
Bergman, Å., Heindel, J., Jobling, S., Kidd, K., & Zoeller, R. T. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.03.020 · Cited by 1,388
Norman, R. J., Dewailly, D., Legro, R. S., & Hickey, T. E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61345-2 · Cited by 1,360
Criteria, Prevalence, and Phenotypes of Polycystic Ovary Syndrome
Lizneva, D., Suturina, L., Walker, W., Brakta, S., Gavrilova-Jordan, L., & Azziz, R. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.05.003 · Cited by 1,358
Dumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1018 · Cited by 1,020
Self-citationWild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2724 · Cited by 1,010
“The former non-NIH criteria include more women (17) and increase heterogeneity of PCOS phenotypic expression.”
BackgroundLim, S. S., Davies, M. J., Norman, R. J., & Moran, L. J. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms030 · Cited by 939
Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment
Kawamura, K., Cheng, Y., Suzuki, N., Deguchi, M., Sato, Y., Takae, S., Ho, C.-H., Kawamura, N., Tamura, M., Hashimoto, S., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312830110 · Cited by 863
Franks, S. (1997) · Archives of Disease in Childhood · doi:10.1136/adc.77.1.89 · Cited by 806
Intraovarian Control of Early Folliculogenesis
Hsueh, A. J. W., Kawamura, K., Cheng, Y., & Fauser, B. C. J. M. (2015) · Endocrine Reviews · doi:10.1210/er.2014-1020 · Cited by 702
Self-citationThe Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review
Pundir, C., Deswal, R., Narwal, V., & Dang, A. (2020) · Journal of Human Reproductive Sciences · doi:10.4103/jhrs.jhrs_95_18 · Cited by 657
Barry, J. A., Azizia, M. M., & Hardiman, P. J. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu012 · Cited by 597
The effect of obesity on polycystic ovary syndrome: a systematic review and meta‐analysis
Lim, S. S., Norman, R. J., Davies, M. J., & Moran, L. J. (2013) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01053.x · Cited by 539
“For study inclusion, PCOS was defined according to the NIH (5) or ESHRE/ASRM (45) criteria.”
BackgroundMethodInfluentialA European Evidence-Based Guideline for the Prevention of Type 2 Diabetes
Paulweber, B., Valensi, P., Lindström, J., Lalic, N., Greaves, C., McKee, M., Kissimova-Skarbek, K., Liatis, S., Cosson, E., Szendroedi, J., et al. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0029-1240928 · Cited by 469
Geographical Prevalence of Polycystic Ovary Syndrome as Determined by Region and Race/Ethnicity
Wolf, W. M., Wattick, R. A., Kinkade, O. N., & Olfert, M. D. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15112589 · Cited by 413
Impact of Obesity on the Risk for Polycystic Ovary Syndrome
Yildiz, B. O., Knochenhauer, E. S., & Azziz, R. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1834 · Cited by 401
“the use of the Rotterdam 2003 criteria, would have increased the number of individuals diagnosed as having PCOS, possibly even doubling their number (32).”
Methodde Groot, P. C. M., Dekkers, O. M., Romijn, J. A., Dieben, S. W. M., & Helmerhorst, F. M. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmr001 · Cited by 394
Metabolic features of the reproductive phenotypes of polycystic ovary syndrome
Moran, L., & Teede, H. (2009) · Human Reproduction Update · doi:10.1093/humupd/dmp008 · Cited by 362
Lim, S. S., Kakoly, N. S., Tan, J. W. J., Fitzgerald, G., Bahri Khomami, M., Joham, A. E., Cooray, S. D., Misso, M. L., Norman, R. J., Harrison, C. L., et al. (2019) · Obesity Reviews · doi:10.1111/obr.12762 · Cited by 316
“For study inclusion, PCOS was diagnosed using the original National Institute of Health (30) criteria of chronic anovulation and clinical or biochemical hyperandrogenism with exclusion of other etiologies, or the European Society for Human Reproduction and Embryology/American Society for Reproductive Medicine (ESHRE/A…”
MethodDeconstructing a Syndrome: Genomic Insights Into PCOS Causal Mechanisms and Classification
Dapas, M., & Dunaif, A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac001 · Cited by 300
Polycystic ovarian syndrome: Pathophysiology, molecular aspects and clinical implications
Diamanti-Kandarakis, E. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000598 · Cited by 294
Tehrani, F., Simbar, M., Tohidi, M., Hosseinpanah, F., & Azizi, F. (2011) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-9-39 · Cited by 290
Complications and challenges associated with polycystic ovary syndrome: current perspectives
Palomba, S., Santagni, S., Falbo, A., & La Sala, G. B. (2015) · International Journal of Women's Health · doi:10.2147/ijwh.s70314 · Cited by 287
Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review
Chittenden, B., Fullerton, G., Maheshwari, A., & Bhattacharya, S. (2009) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60175-7 · Cited by 279
Pathophysiological roles of chronic low‐grade inflammation mediators in polycystic ovary syndrome
Rostamtabar, M., Esmaeilzadeh, S., Tourani, M., Rahmani, A., Baee, M., Shirafkan, F., Saleki, K., Mirzababayi, S. S., Ebrahimpour, S., & Nouri, H. R. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.29912 · Cited by 264
Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome
Moghetti, P., Tosi, F., Bonin, C., Di Sarra, D., Fiers, T., Kaufman, J.-M., Giagulli, V. A., Signori, C., Zambotti, F., Dall'Alda, M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3908 · Cited by 262
“With regard to PCOS phenotypes, most previous studies reported that women with the classic phenotype were more insulin resistant than those with either the ovulatory (43, 48–53) or the normoandrogenic phenotype (35, 37, 41, 43, 47, 50, 52, 54).”
Polycystic ovary syndrome current status and future perspective
Naz, R. K. (2014) · Frontiers in Bioscience · doi:10.2741/e695 · Cited by 259
Serum Anti-Müllerian Hormone Levels in Healthy Females: A Nomogram Ranging from Infancy to Adulthood
Lie Fong, S., Visser, J. A., Welt, C. K., de Rijke, Y. B., Eijkemans, M. J. C., Broekmans, F. J., Roes, E. M., Peters, W. H. M., Hokken-Koelega, A. C. S., Fauser, B. C. J. M., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1440 · Cited by 259
Self-citationBarber, T. M., Wass, J. A. H., McCarthy, M. I., & Franks, S. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02764.x · Cited by 254
ACOG Practice Bulletin No. 194: polycystic ovary syndrome
(2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002656 · Cited by 231
Daan, N. M. P., Louwers, Y. V., Koster, M. P. H., Eijkemans, M. J. C., de Rijke, Y. B., Lentjes, E. W. G., Fauser, B. C. J. M., & Laven, J. S. E. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.08.001 · Cited by 217
Self-citationLegro, R. S., Schlaff, W. D., Diamond, M. P., Coutifaris, C., Casson, P. R., Brzyski, R. G., Christman, G. M., Trussell, J. C., Krawetz, S. A., Snyder, P. J., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1123 · Cited by 213
“Because our study only included hyperandrogenemic women, we selected against normoandrogenic PCOS and probably less severe phenotypes (20, 21).”
BackgroundPanidis, D., Tziomalos, K., Misichronis, G., Papadakis, E., Betsas, G., Katsikis, I., & Macut, D. (2012) · Human Reproduction · doi:10.1093/humrep/der418 · Cited by 155
Goverde, A. J., van Koert, A. J. B., Eijkemans, M. J., Knauff, E. A. H., Westerveld, H. E., Fauser, B. C. J. M., & Broekmans, F. J. (2008) · Human Reproduction · doi:10.1093/humrep/den433 · Cited by 135
Self-citationLim, S., Smith, C. A., Costello, M. F., MacMillan, F., Moran, L., & Ee, C. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0434-8 · Cited by 105
Estrogen deprivation and cardiovascular disease risk in primary ovarian insufficiency
Christ, J. P., Gunning, M. N., Palla, G., Eijkemans, M. J. C., Lambalk, C. B., Laven, J. S. E., & Fauser, B. C. J. M. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.11.035 · Cited by 102
Self-citationFruzzetti, F., Perini, D., Lazzarini, V., Parrini, D., & Genazzani, A. R. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.004 · Cited by 95
Zhang, H. Y., Guo, C. X., Zhu, F. F., Qu, P. P., Lin, W. J., & Xiong, J. (2013) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-012-2568-z · Cited by 94
Panidis, D., Tziomalos, K., Papadakis, E., Vosnakis, C., Chatzis, P., & Katsikis, I. (2013) · Endocrine · doi:10.1007/s12020-013-9971-5 · Cited by 93
Metabolic effect of obesity on polycystic ovary syndrome in adolescents: a meta-analysis
Li, L., Feng, Q., Ye, M., He, Y., Yao, A., & Shi, K. (2017) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2017.1318840 · Cited by 85
Moran, L. J., Tassone, E. C., Boyle, J., Brennan, L., Harrison, C. L., Hirschberg, A. L., Lim, S., Marsh, K., Misso, M. L., Redman, L., et al. (2020) · Obesity Reviews · doi:10.1111/obr.13046 · Cited by 84
The Polycystic Ovary Syndrome and recent human evolution
Corbett, S., & Morin-Papunen, L. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.01.001 · Cited by 68
Barth, J. H., Field, H. P., Yasmin, E., & Balen, A. H. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0741 · Cited by 69
Corbett, S. J., McMichael, A. J., & Prentice, A. M. (2009) · American Journal of Human Biology · doi:10.1002/ajhb.20937 · Cited by 64
Weight management interventions in women with and without PCOS: a systematic review
Kataoka, J., Tassone, E., Misso, M., Joham, A., Stener-Victorin, E., Teede, H., & Moran, L. (2017) · Nutrients · doi:10.3390/nu9090996 · Cited by 58
Jiskoot, G., Benneheij, S. H., Beerthuizen, A., de Niet, J. E., de Klerk, C., Timman, R., Busschbach, J. J., & Laven, J. S. E. (2017) · Reproductive Health · doi:10.1186/s12978-017-0295-4 · Cited by 50
Self-citationWang, Q., Sun, Y., Xu, Q., Liu, W., Wang, P., Yao, J., Zhao, A., Chen, Y., & Wang, W. (2022) · Nutrition Research · doi:10.1016/j.nutres.2021.12.006 · Cited by 49
Hasan, M., Sultana, S., Sohan, M., Parvin, S., Rahman, M. A., Hossain, M. J., Rahman, M. S., & Islam, M. R. (2022) · PLOS ONE · doi:10.1371/journal.pone.0270102 · Cited by 45
Diabetes risk score in the diagnostic categories of polycystic ovary syndrome
Moran, L. J., Strauss, B. J., & Teede, H. J. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.01.133 · Cited by 41
“This is not consistently observed and insulin resistance or glucose intolerance was reported for NIH compared with ovulatory (31) or nonhyperandrogenic (30) non-NIH PCOS or for ovulatory non-NIH PCOS compared with controls (35), despite comparison of obese subsets only (30) or similar weight and waist-hip ratio (31, 3…”
BackgroundTranstheoretical model-based mobile health application for PCOS
Wang, L., Liu, Y., Tan, H., & Huang, S. (2022) · Reproductive Health · doi:10.1186/s12978-022-01422-w · Cited by 38
Lin, S., Deng, Y., Huang, J., Li, M., Sooranna, S. R., Qin, M., & Tan, B. (2025) · Scientific Reports · doi:10.1038/s41598-025-99622-4 · Cited by 35
Antonio, L., Pauwels, S., Laurent, M. R., Vanschoubroeck, D., Jans, I., Billen, J., Claessens, F., Decallonne, B., De Neubourg, D., Vermeersch, P., et al. (2018) · International Journal of Endocrinology · doi:10.1155/2018/7956951 · Cited by 30
Skiba, M. A., Bell, R. J., Herbert, D., Garcia, A. M., Islam, R. M., & Davis, S. R. (2021) · Human Reproduction · doi:10.1093/humrep/deab069 · Cited by 22
Enhancing polycystic ovarian syndrome awareness using private social network
Alotaibi, M., & Shaman, A. A. (2020) · mHealth · doi:10.21037/mhealth.2019.12.02 · Cited by 21
Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome
Barber, T. M., & Franks, S. (2013) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2013.827373 · Cited by 15
Health literacy needs in weight management of women with Polycystic Ovary Syndrome
Lim, S., Smith, C. A., Costello, M. F., MacMillan, F., Moran, L., Teede, H., & Ee, C. (2021) · Health Promotion Journal of Australia · doi:10.1002/hpja.349 · Cited by 14
Lim, S., Wright, B., Savaglio, M., Goodwin, D., Pirotta, S., & Moran, L. (2021) · Seminars in Reproductive Medicine · doi:10.1055/s-0041-1735575 · Cited by 10
Fetal androgen excess provides a developmental origin for polycystic ovary syndrome
Abbott, D. H., & Dumesic, D. A. (2009) · Expert Review of Obstetrics & Gynecology · doi:10.1586/17474108.4.1.1 · Cited by 11
Kim, N., & Chun, S. (2021) · Clinical and Experimental Reproductive Medicine · doi:10.5653/cerm.2021.04553 · Cited by 10
“Common metabolic problems associated with PCOS are glucose intolerance, type 2 diabetes mellitus (T2DM), central obesity, insulin resistance, and hyperinsulinemia [1-6].”
BackgroundInfluentialThe Epidemiology of Polycystic Ovary Syndrome
Suturina, L. (2022) · Polycystic Ovary Syndrome · doi:10.1017/9781108989831.003 · Cited by 4
Metadata
- Authors
- Broekmans, F., Knauff, E., Valkenburg, O., Laven, J., Eijkemans, M., & Fauser, B.
- Venue
- BJOG: An International Journal of Obstetrics & Gynaecology
- Publisher
- Wiley
- Published
- 2006-08-10
- Volume
- 113
- Issue
- 10
- Pages
- 1210-1217
- ISSN
- 0306-5456 (ISSN-L)
- 1470-0328
- 1471-0528
- OpenAlex
- W2133421321
- Cited by
- 442
- References
- 64
- FWCI
- 17.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.